Part 4 - TREATMENT GUIDELINES
- Section 63-1-401 - Part definitions - Development of recommended treatment guidelines for prescribing opioids - Development of pain clinic guidelines - Study of co-prescription of naloxone with opioid - Review of guidelines - Notification of licensees
- Section 63-1-402 - Prescribers required to hold a current federal DEA license and to complete continuing education - Exceptions to application of part
- Section 63-1-403 - Nonresidential buprenorphine treatment guidelines